---
figid: PMC8102455__40265_2021_1486_Fig2_HTML
figtitle: 'Fabry Disease: The Current Treatment Landscape'
organisms:
- Nicotiana tabacum
- Physcomitrium patens
- Tacca leontopetaloides
- Mus musculus
- Cricetulus griseus
- Homo sapiens
- adeno-associated virus 2
pmcid: PMC8102455
filename: 40265_2021_1486_Fig2_HTML.jpg
figlink: /pmc/articles/PMC8102455/figure/Fig2/
number: F2
caption: Overview of the ceramide pathway and therapeutic targets of Fabry disease-specific
  approved and future treatments. AGAL/GLA α-galactosidase A, loss of function results
  in Fabry disease, A4GALT α-1,4-galactosyltransferase, B3GALNT1 β-1,3-N-acetylgalactosaminyltransferase
  1, B4GALT6 β-1,4-galactosyltransferase 6, GBA glucosylceramidase beta, loss of function
  results in Gaucher disease, GCS glucosylceramide synthase, GLB1 galactosidase-beta
  1, loss of function results in GM1 gangliosidosis, HEXA hexosaminidase-subunit alpha,
  loss of function results in GM2 gangliosidosis
papertitle: 'Fabry Disease: The Current Treatment Landscape.'
reftext: Malte Lenders, et al. Drugs. 2021;81(6):635-645.
year: '2021'
doi: 10.1007/s40265-021-01486-1
journal_title: Drugs
journal_nlm_ta: Drugs
publisher_name: Springer International Publishing
keywords: ''
automl_pathway: 0.8551399
figid_alias: PMC8102455__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Cricetulus griseus
- Mus musculus
redirect_from: /figures/PMC8102455__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8102455__40265_2021_1486_Fig2_HTML.html
  '@type': Dataset
  description: Overview of the ceramide pathway and therapeutic targets of Fabry disease-specific
    approved and future treatments. AGAL/GLA α-galactosidase A, loss of function results
    in Fabry disease, A4GALT α-1,4-galactosyltransferase, B3GALNT1 β-1,3-N-acetylgalactosaminyltransferase
    1, B4GALT6 β-1,4-galactosyltransferase 6, GBA glucosylceramidase beta, loss of
    function results in Gaucher disease, GCS glucosylceramide synthase, GLB1 galactosidase-beta
    1, loss of function results in GM1 gangliosidosis, HEXA hexosaminidase-subunit
    alpha, loss of function results in GM2 gangliosidosis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GCLC
  - UGCG
  - GBA1
  - GBA1LP
  - GLB1
  - B4GALT6
  - A4GALT
  - A4GNT
  - GLA
  - NAT8
  - HEXA
  - B3GALNT1
  - Gba1
  - Glb1
  - B4galt6
  - A4galt
  - Gla
  - Hexa
  - B3galnt1
---
